Peripheral blood stem cell mobilization: New regimens, new cells, where do we stand

Louis Pelus

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Purpose of Review: Granulocyte colony-stimulating factor-mobilized peripheral blood stem cells are widely used to reconstitute hematopoiesis; however, preclinical and clinical studies show that improvements to this mobilization can be achieved. We discuss the development of new mobilizing regimens and evaluation of new findings on mobilized stem cell populations that may improve the utility and convenience of peripheral blood stem cell transplant. Recent Findings: Chemokines and their receptors regulate leukocyte trafficking, and altering chemokine signaling pathways mobilizes stem cells. In recent trials, combination use of the chemokine (C-X-C motif) receptor 4 antagonist AMD3100 and granulocyte colony-stimulating factor mobilized more CD34 cells in fewer days than granulocyte colony-stimulating factor alone and allowed more patients to proceed to autotransplant. In preclinical studies the chemokine GROβ synergizes with granulocyte colony-stimulating factor and when used alone or with granulocyte colony-stimulating factor mobilizes more primitive hematopoietic stem cells with less apoptosis, higher integrin activation, lower CD26 expression and enhanced marrow homing compared with granulocyte colony-stimulating factor. Hematopoietic stem cells mobilized by GROβ or AMD3100 demonstrate superior engraftment and contribution to chimerism in primary and secondary transplant studies in mice, and peripheral blood stem cells mobilized by AMD3100 and granulocyte colony-stimulating factor in patients demonstrate enhanced engraftment capabilities in immunodeficient mice. Summary: Alternate regimens differentially mobilize stem cell populations with unique intrinsic properties with the potential to expand the utility of hematopoietic transplantation. Continued mechanistic evaluation will be critical to our understanding of mechanisms of mobilization and their use in regenerative medicine.

Original languageEnglish
Pages (from-to)285-292
Number of pages8
JournalCurrent Opinion in Hematology
Volume15
Issue number4
DOIs
StatePublished - Jul 2008

Fingerprint

Hematopoietic Stem Cell Mobilization
Granulocyte Colony-Stimulating Factor
Stem Cells
Hematopoietic Stem Cells
Chemokines
CCR Receptors
Transplants
Chimerism
Regenerative Medicine
Chemokine Receptors
Hematopoiesis
Autografts
Peripheral Blood Stem Cells
Integrins
Population
Leukocytes
Transplantation
Bone Marrow
Apoptosis

Keywords

  • Hematopoietic transplantation
  • Peripheral blood stem cell mobilization
  • Stem cells

ASJC Scopus subject areas

  • Hematology

Cite this

Peripheral blood stem cell mobilization : New regimens, new cells, where do we stand. / Pelus, Louis.

In: Current Opinion in Hematology, Vol. 15, No. 4, 07.2008, p. 285-292.

Research output: Contribution to journalArticle

@article{ff226db9543847efbe3ac7dcd110a617,
title = "Peripheral blood stem cell mobilization: New regimens, new cells, where do we stand",
abstract = "Lippincott Williams & Wilkins.",
keywords = "Hematopoietic transplantation, Peripheral blood stem cell mobilization, Stem cells",
author = "Louis Pelus",
year = "2008",
month = "7",
doi = "10.1097/MOH.0b013e328302f43a",
language = "English",
volume = "15",
pages = "285--292",
journal = "Current Opinion in Hematology",
issn = "1065-6251",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Peripheral blood stem cell mobilization

T2 - New regimens, new cells, where do we stand

AU - Pelus, Louis

PY - 2008/7

Y1 - 2008/7

N2 - Lippincott Williams & Wilkins.

AB - Lippincott Williams & Wilkins.

KW - Hematopoietic transplantation

KW - Peripheral blood stem cell mobilization

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=47149117791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47149117791&partnerID=8YFLogxK

U2 - 10.1097/MOH.0b013e328302f43a

DO - 10.1097/MOH.0b013e328302f43a

M3 - Article

C2 - 18536564

AN - SCOPUS:47149117791

VL - 15

SP - 285

EP - 292

JO - Current Opinion in Hematology

JF - Current Opinion in Hematology

SN - 1065-6251

IS - 4

ER -